Risk factors associated with short-term post-treatment outcomes of clinical mastitis

被引:150
作者
Pinzon-Sanchez, C. [1 ]
Ruegg, P. L. [1 ]
机构
[1] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA
关键词
mastitis; treatment; dairy; milk quality; FACTORS AFFECTING CURE; HOLSTEIN DAIRY-COWS; SOMATIC-CELL COUNT; NEW-YORK-STATE; STAPHYLOCOCCUS-AUREUS; MILK-YIELD; ANTIMICROBIAL SUSCEPTIBILITY; INTRAMAMMARY INFECTIONS; SUBCLINICAL MASTITIS; LACTATING COWS;
D O I
10.3168/jds.2010-3925
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
The objectives of this study were to characterize 60-d outcomes after treatment of mild (abnormal milk) and moderate (abnormal milk and abnormal udder) cases of clinical mastitis (CM) occurring in a single quarter of cows on Wisconsin farms (n = 4) and to determine risk factors associated with those outcomes. Duplicate milk samples were collected from the affected quarter of each cow for microbiological analysis at the onset of CM (PRE) and 21 d later (POST). Cows were treated only in the affected quarter using an intramammary product containing 125 mg of ceftiofur. Bacteriological cure was defined as absence of pathogens in the POST sample obtained from the enrolled quarter. Recurrence was defined for the cow when CM occurred after the milk-withholding period for the enrolled case of CM. Retention in the herd was defined when a cow was retained within the herd for the 60-d follow-up period. Somatic cell count reduction (SCCR) was defined at the cow level as somatic cell count (SCC) below 200,000 cells/mL at the Dairy Herd Improvement Association test day occurring between 21 to 55 d post-treatment. The effects of farm, clays in milk, parity, severity, microbiological diagnosis at PRE, previous milk yield, previous SCC, previous occurrence of CM and treatment duration on selected post-treatment outcomes were assessed using Chi-squared analysis and logistic regression. Microbiological results at PRE were distributed as: Escherichia coli (n = 14), Klebsiella spp. (n = 11), Enterobacter spp. (n = 8), Serratia spp. (n = 7), other gram-negative species (n = 3), Streptococcus spp. (n = 25), coagulase-negative staphylococci (n = 4); Staphylococcus aureus (n = 1); Streptococcus agalactiae (n = 1), other gram-positive species (n = 9), and culture negative (n = 60). Treated quarters were more likely to experience bacteriological cure when the cow experienced CM for the first time in the lactation and when no pathogen was recovered from PRE milk samples obtained from the enrolled quarter. Parity and bacteriological cure were associated with the probability of recurrence. Greater milk yield at previous Dairy Herd Improvement test was the most important predictor for retention within the herd. When SCC before CM was >200,000 cells/mL the probability of having SCCR after treatment was decreased. When the case experienced bacteriological cure, the cow was less likely to experience recurrent cases and was more likely to have SCCR below 200,000 cells/mL. Post-treatment outcomes, such as recurrence and SCCR, are strongly associated with bacteriological cure and, when monitored, can be used to help determine if a treatment has been successful. Information about the etiology of CM, history of clinical and subclinical mastitis, and parity are useful to review when making strategic treatment decisions.
引用
收藏
页码:3397 / 3410
页数:14
相关论文
共 41 条
  • [1] Diagnosing intramammary infections: Evaluating expert opinions on the definition of intramammary infection using conjoint analysis
    Andersen, S.
    Dohoo, I. R.
    Riekerink, R. Olde
    Stryhn, H.
    [J]. JOURNAL OF DAIRY SCIENCE, 2010, 93 (07) : 2966 - 2975
  • [2] Relationship between in vitro susceptibility test results and treatment outcomes for gram-positive mastitis pathogens following treatment with cephapirin sodium
    Apparao, M. D.
    Ruegg, P. L.
    Lago, A.
    Godden, S.
    Bey, R.
    Leslie, K.
    [J]. JOURNAL OF DAIRY SCIENCE, 2009, 92 (06) : 2589 - 2597
  • [3] Effect of repeated episodes of generic clinical mastitis on milk yield in dairy cows
    Bar, D.
    Groehn, Y. T.
    Bennett, G.
    Gonzalez, R. N.
    Hertl, J. A.
    Schulte, H. F.
    Tauer, L. W.
    Welcome, F. L.
    Schukken, Y. H.
    [J]. JOURNAL OF DAIRY SCIENCE, 2007, 90 (10) : 4643 - 4653
  • [4] Invited review:: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis
    Barkema, H. W.
    Schukken, Y. H.
    Zadoks, R. N.
    [J]. JOURNAL OF DAIRY SCIENCE, 2006, 89 (06) : 1877 - 1895
  • [5] BOWMAN GL, 1986, J AM VET MED ASSOC, V189, P913
  • [6] Factors affecting cure when treating bovine clinical mastitis with cephalosporin-based intramammary preparations
    Bradley, A. J.
    Green, M. J.
    [J]. JOURNAL OF DAIRY SCIENCE, 2009, 92 (05) : 1941 - 1953
  • [7] Treatment of clinical mastitis using antimicrobial susceptibility profiles for treatment decisions
    Constable, PD
    Morin, DE
    [J]. VETERINARY CLINICS OF NORTH AMERICA-FOOD ANIMAL PRACTICE, 2003, 19 (01) : 139 - +
  • [8] Associations between pathogen-specific cases of clinical mastitis and somatic cell count patterns
    de Haas, Y
    Veerkamp, RF
    Barkema, HW
    Gröhn, YT
    Schukken, YH
    [J]. JOURNAL OF DAIRY SCIENCE, 2004, 87 (01) : 95 - 105
  • [9] Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows
    Deluyker, HA
    Van Oye, SN
    Boucher, JF
    [J]. JOURNAL OF DAIRY SCIENCE, 2005, 88 (02) : 604 - 614
  • [10] DINSMORE RP, 1992, J DAIRY SCI, V75, P2706, DOI 10.3168/jds.S0022-0302(92)78032-1